Results from Harmony: An open-label, multicenter, 2-arm, phase 1b, dose-finding study assessing the safety and efficacy of the oral combination of ruxolitinib and buparlisib in patients with myelofibrosis

Simon T. Durrant, Arnon Nagler, Paola Guglielmelli, David Lavie, Philipp le Coutre, Heinz Gisslinger, Charles Chuah, Margherita Maffioli, Savita Bharathy, Tuochuan Dong, Monika Wroclawska, Joaquin Martinez Lopez

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)E551-E554
JournalHaematologica
Volume104
Issue number12
DOIs
StatePublished - 2019
Externally publishedYes

Cite this